drugset / Trial / NCT00813488

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

NCT00813488

Phase 3 Completed 213 enrolled Cephalon
RandomizedCrossoverQuadruple-blindTreatment

Summary

Evaluate the efficacy of treatment with the fentanyl buccal tablet (FBT) compared with immediate release oxycodone treatment in alleviating breakthrough pain (BTP) in opioid tolerant patients with chronic pain.

Timeline

Start
2008-12
Primary completion
2009-11
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 200 ug
Subject Fentanyl Other / unclassified 400 ug
Subject Fentanyl Other / unclassified 600 ug
Subject Fentanyl Other / unclassified 800 ug
Subject Oxycodone Other / unclassified 15 mg
Subject Oxycodone Other / unclassified 30 mg
Subject Oxycodone Other / unclassified 45 mg
Subject Oxycodone Other / unclassified 60 mg

Indications